| 1 | Urticaria Pigmentosa | 36.5% |
| 2 | Chondrosarcoma | 26.7% |
| 3 | synovial sarcoma | 26.7% |
| 4 | Clear Cell Sarcoma of Soft Tissue | 26.7% |
| 5 | Mastocytosis, Systemic | 25% |
| 6 | Myxoma | 24.3% |
| 7 | Neoplasms, Bone Tissue | 24.3% |
| 8 | Neoplasms, Fibrous Tissue | 24.3% |
| 9 | Chondroma | 24.3% |
| 10 | Enchondroma | 24.3% |
| 11 | Giant Cell Tumor of Bone | 24.1% |
| 12 | Pyoderma Gangrenosum | 23.8% |
| 13 | Fibrosarcoma | 20.6% |
| 14 | Osteosarcoma | 20.6% |
| 15 | Lupus Erythematosus, Cutaneous | 20.4% |
| 16 | Panniculitis | 20.4% |
| 17 | Systemic Scleroderma | 20.4% |
| 18 | Morphea | 20.4% |
| 19 | Breast Diseases | 20.1% |
| 20 | Dermatitis | 20.1% |
| 21 | Exanthema | 20.1% |
| 22 | Facial Dermatoses | 20.1% |
| 23 | Hair Diseases | 20.1% |
| 24 | Hand Dermatoses | 20.1% |
| 25 | keratoacanthoma | 20.1% |
| 26 | Keratosis | 20.1% |
| 27 | Nail Diseases | 20.1% |
| 28 | Photosensitivity Disorders | 20.1% |
| 29 | Prurigo | 20.1% |
| 30 | Pyoderma | 20.1% |
| 31 | Rosacea | 20.1% |
| 32 | Sebaceous Gland Diseases | 20.1% |
| 33 | Skin Diseases, Vesiculobullous | 20.1% |
| 34 | Skin Ulcer | 20.1% |
| 35 | Sweat Gland Diseases | 20.1% |
| 36 | Skin Diseases, Papulosquamous | 20.1% |
| 37 | Skin Diseases, Vascular | 20.1% |
| 38 | Acneiform Eruptions | 20.1% |
| 39 | Ocular Rosacea | 20.1% |
| 40 | Subcorneal pustular dermatosis | 20.1% |
| 41 | Erythematotelangiectatic Rosacea | 20.1% |
| 42 | Papulopustular Rosacea | 20.1% |
| 43 | Chronic Actinic Dermatitis | 20.1% |
| 44 | Acne Vulgaris | 19.8% |
| 45 | Contact Dermatitis | 19.8% |
| 46 | Eczema | 19.8% |
| 47 | Erythema Multiforme | 19.8% |
| 48 | Intertrigo | 19.8% |
| 49 | Neurodermatitis | 19.8% |
| 50 | Rhinophyma | 19.8% |
| 51 | Perioral Dermatitis | 19.8% |
| 52 | Acne | 19.8% |
| 53 | Skin Neoplasms | 19.1% |
| 54 | Sarcoma | 19.1% |
| 55 | Xeroderma Pigmentosum | 17.5% |
| 56 | Malignant Fibrous Histiocytoma | 17.5% |
| 57 | Sebaceous Gland Neoplasms | 17.5% |
| 58 | Dermatitis, Phototoxic | 17.5% |
| 59 | Pityriasis Lichenoides et Varioliformis Acuta | 17.5% |
| 60 | Pityriasis Lichenoides | 17.5% |
| 61 | Phototoxicity | 17.5% |
| 62 | Foot Ulcer | 17.1% |
| 63 | Dermatitis, Atopic | 17% |
| 64 | Epidermolysis Bullosa | 17% |
| 65 | leiomyosarcoma | 17% |
| 66 | liposarcoma | 17% |
| 67 | Angiomyolipoma | 17% |
| 68 | Alveolar Soft Part Sarcoma | 17% |
| 69 | fibroma | 16.1% |
| 70 | Fibromatosis | 16.1% |
| 71 | Osteoblastoma | 16.1% |
| 72 | Osteoma | 16.1% |
| 73 | Chondromatosis | 16.1% |
| 74 | Dermatitis Herpetiformis | 16.1% |
| 75 | Foot Diseases | 15.9% |
| 76 | Acrodermatitis | 15.8% |
| 77 | Porokeratosis | 15.8% |
| 78 | Gianotti-Crosti Syndrome | 15.8% |
| 79 | Keratoderma, Palmoplantar | 15.8% |
| 80 | Skin Abnormalities | 15.3% |
| 81 | Skin Diseases, Infectious | 15.3% |
| 82 | Pigmentation Disorders | 15.3% |
| 83 | Panniculitis, Lupus Erythematosus | 15.3% |
| 84 | leukemia | 15.1% |
| 85 | Neoplasms, Germ Cell and Embryonal | 15.1% |
| 86 | Neoplasms, Glandular and Epithelial | 15.1% |
| 87 | Germ Cell Cancer | 15.1% |
| 88 | Lipomatosis | 15.1% |
| 89 | Pruritus | 15.1% |
| 90 | Erythema | 15.1% |
| 91 | Necrolytic Migratory Erythema | 15.1% |
| 92 | Cutaneous Fistula | 15.1% |
| 93 | Nephrogenic Fibrosing Dermopathy | 15.1% |
| 94 | Nephrogenic Systemic Fibrosis | 15.1% |
| 95 | Necrobiosis Lipoidica Diabeticorum | 14.8% |
| 96 | Gastrointestinal Stromal Tumors | 14.8% |
| 97 | Carcinosarcoma | 14.7% |
| 98 | Hemangiosarcoma | 14.7% |
| 99 | lymphangiosarcoma | 14.7% |
| 100 | Dermatofibrosarcoma | 14.6% |
| 101 | Dermatofibrosarcoma Protuberans | 14.6% |
| 102 | Dermatitis, Irritant | 14.6% |
| 103 | Acne Conglobata | 14.6% |
| 104 | Dermatitis, Photoallergic | 14.6% |
| 105 | Breast Cyst | 13.8% |
| 106 | Actinic keratosis | 13.8% |
| 107 | Xeroderma | 13.4% |
| 108 | Dermatomyositis | 13.3% |
| 109 | Lupus Erythematosus, Discoid | 13.2% |
| 110 | Scleroderma, Limited | 13.2% |
| 111 | Anhidrosis | 13.1% |
| 112 | Cholesteatoma | 13.1% |
| 113 | Pressure Ulcer | 13.1% |
| 114 | Folliculitis | 13.1% |
| 115 | Foot Dermatoses | 13.1% |
| 116 | Gynecomastia | 13.1% |
| 117 | Hypertrichosis | 13.1% |
| 118 | Hypohidrosis | 13.1% |
| 119 | Hypotrichosis | 13.1% |
| 120 | Leg Ulcer | 13.1% |
| 121 | Miliaria | 13.1% |
| 122 | Parakeratosis | 13.1% |
| 123 | Parapsoriasis | 13.1% |
| 124 | Pityriasis | 13.1% |
| 125 | Psoriasis | 13.1% |
| 126 | Sweet Syndrome | 13.1% |
| 127 | Hidradenitis | 13.1% |
| 128 | Onycholysis | 13.1% |
| 129 | Miliaria Rubra | 13.1% |
| 130 | Hyperpigmentation | 13.1% |
| 131 | Lichenoid Eruptions | 13.1% |
| 132 | Chloracne | 13.1% |
| 133 | Erythema Induratum | 12.8% |
| 134 | Adenofibroma | 12.7% |
| 135 | Fibroadenoma | 12.7% |
| 136 | Neuroectodermal Tumors | 12.3% |
| 137 | Dermatitis, Occupational | 12.2% |
| 138 | Sarcoma, Myeloid | 12.1% |
| 139 | Fibromatosis, Aggressive | 12.1% |
| 140 | Fibromatosis, Abdominal | 12.1% |
| 141 | Diaper Rash | 12% |
| 142 | Cutis Laxa | 12% |
| 143 | Dermatitis, Allergic Contact | 11.7% |
| 144 | Connective Tissue Diseases | 11.7% |
| 145 | Papillon-Lefevre Disease | 11.7% |
| 146 | Erythema Infectiosum | 11.6% |
| 147 | Exanthema Subitum | 11.6% |
| 148 | Dupuytren Contracture | 11.4% |
| 149 | Erythema Nodosum | 11.4% |
| 150 | Phyllodes Tumor | 11.4% |
| 151 | Lipoma | 11.4% |
| 152 | Myoma | 11.4% |
| 153 | Angiolipoma | 11.4% |
| 154 | Myelolipoma | 11.4% |
| 155 | Smooth Muscle Tumor | 11.4% |
| 156 | Desmoplastic Small Round Cell Tumor | 11.4% |
| 157 | Ectodermal Dysplasia | 11.3% |
| 158 | Aplasia Cutis Congenita | 11.3% |
| 159 | Histiocytic Disorders, Malignant | 11.3% |
| 160 | Rhabdomyosarcoma | 11.2% |
| 161 | Pseudoxanthoma Elasticum | 11.1% |
| 162 | Toxic Epidermal Necrolysis | 11% |
| 163 | Stevens-Johnson Syndrome | 11% |
| 164 | Neoplasms, Neuroepithelial | 10.7% |
| 165 | Gliomatosis cerebri | 10.7% |
| 166 | Carcinoma 256, Walker | 10.5% |
| 167 | Tinea Capitis | 10.5% |
| 168 | Onychomycosis | 10.5% |
| 169 | Carcinoma, Lobular | 10.3% |
| 170 | Acantholysis | 10% |
| 171 | Pemphigoid, Benign Mucous Membrane | 10% |
| 172 | Pemphigus | 10% |
| 173 | Piedra | 10% |
| 174 | Sunburn | 10% |
| 175 | Hamartoma | 9.9% |
| 176 | Neoplasms, Hormone-Dependent | 9.9% |
| 177 | Neoplasms, Multiple Primary | 9.9% |
| 178 | Paraneoplastic Syndromes | 9.9% |
| 179 | Precancerous Conditions | 9.9% |
| 180 | Neoplasms, Second Primary | 9.9% |
| 181 | Sarcoma, Experimental | 9.9% |
| 182 | Argyria | 9.9% |
| 183 | Hirsutism | 9.9% |
| 184 | Lactation Disorder | 9.9% |
| 185 | Mastitis | 9.9% |
| 186 | Urticaria | 9.9% |
| 187 | Granuloma Annulare | 9.8% |
| 188 | Adiposis Dolorosa | 9.8% |
| 189 | Pruritus Vulvae | 9.8% |
| 190 | Ecthyma | 9.8% |
| 191 | Pruritus Ani | 9.8% |
| 192 | Lichen Planus | 9.7% |
| 193 | Melanosis | 9.7% |
| 194 | Chloasma | 9.7% |
| 195 | Pityriasis Rosea | 9.7% |
| 196 | Pityriasis Rubra Pilaris | 9.7% |
| 197 | Vitiligo | 9.7% |
| 198 | Lichen Nitidus | 9.7% |
| 199 | Neurofibrosarcoma | 9.7% |
| 200 | Hyperkeratosis, Epidermolytic | 9.6% |
| 201 | Breast Neoplasms, Male | 9.4% |
| 202 | Triple Negative Breast Neoplasms | 9.4% |
| 203 | Lymphoma | 9% |
| 204 | Ichthyosis, X-Linked | 8.9% |
| 205 | Sjogren-Larsson Syndrome | 8.9% |
| 206 | melanoma | 8.7% |
| 207 | Meningioma | 8.7% |
| 208 | Behcet Syndrome | 8.7% |
| 209 | Alveolar rhabdomyosarcoma | 8.4% |
| 210 | Hidradenitis Suppurativa | 8.4% |
| 211 | Adenoma | 8.2% |
| 212 | Ameloblastoma | 8.2% |
| 213 | Angiokeratoma | 8.2% |
| 214 | Carcinoma | 8.2% |
| 215 | Chordoma | 8.2% |
| 216 | Hemangioma | 8.2% |
| 217 | hemangiopericytoma | 8.2% |
| 218 | Lymphangioma | 8.2% |
| 219 | Mesenchymoma | 8.2% |
| 220 | Nevus | 8.2% |
| 221 | Teratoma | 8.2% |
| 222 | Hepatoblastoma | 8.2% |
| 223 | Mixed Tumor, Mullerian | 8.2% |
| 224 | Germinoma | 8.2% |
| 225 | Teratocarcinoma | 8.2% |
| 226 | Angiofibroma | 8.2% |
| 227 | Epithelioma | 8.2% |
| 228 | Composite Lymphoma | 8.2% |
| 229 | Lymphangioleiomyomatosis | 8.1% |
| 230 | Acanthosis Nigricans | 8.1% |
| 231 | Alopecia Areata | 8.1% |
| 232 | Lentigo | 8.1% |
| 233 | Dermatomycoses | 8% |
| 234 | Mucocutaneous Lymph Node Syndrome | 8% |
| 235 | Trophoblastic Neoplasms | 8% |
| 236 | Skin Diseases, Bacterial | 8% |
| 237 | Leukemia, Experimental | 8% |
| 238 | Drug Eruptions | 7.9% |
| 239 | Lipodystrophy | 7.9% |
| 240 | Livedo Reticularis | 7.9% |
| 241 | Malignant Atrophic Papulosis | 7.9% |
| 242 | Leukemia, Plasma Cell | 7.8% |
| 243 | Polyarteritis Nodosa | 7.8% |
| 244 | Takayasu Arteritis | 7.8% |
| 245 | Endometrial Stromal Sarcoma | 7.8% |
| 246 | Sarcoma 180 | 7.7% |
| 247 | Albinism | 7.7% |
| 248 | Tinea Pedis | 7.6% |
| 249 | Erythema Chronicum Migrans | 7.6% |
| 250 | Rhabdomyoma | 7.5% |
| 251 | Cyst | 7.5% |
| 252 | Neoplastic Processes | 7.5% |
| 253 | Neoplastic Syndromes, Hereditary | 7.5% |
| 254 | Pregnancy Complications, Neoplastic | 7.5% |
| 255 | Alopecia | 7.5% |
| 256 | Carcinoma, Ehrlich Tumor | 7.5% |
| 257 | Dermoid Cyst | 7.5% |
| 258 | Sweating, Gustatory | 7.5% |
| 259 | Androgenetic Alopecia | 7.5% |
| 260 | Auriculotemporal Syndrome | 7.5% |
| 261 | Carcinoma, Lewis Lung | 7.5% |
| 262 | Neoplasms, Experimental | 7.4% |
| 263 | Lice Infestations | 7.3% |
| 264 | Varicose Ulcer | 7.3% |
| 265 | Basal cell carcinoma | 7.3% |
| 266 | Carcinoma, Papillary | 7.3% |
| 267 | Squamous cell carcinoma | 7.3% |
| 268 | Craniopharyngioma | 7.3% |
| 269 | Cystadenoma | 7.3% |
| 270 | Mesothelioma | 7.3% |
| 271 | Neuroectodermal Tumor, Melanotic | 7.3% |
| 272 | Neuroendocrine Tumors | 7.3% |
| 273 | Galactorrhea | 7.3% |
| 274 | Carcinoma, Basal Cell | 7.3% |
| 275 | Myxoid cyst | 7.1% |
| 276 | Nail-Patella Syndrome | 6.8% |
| 277 | Adenoma, Acidophil | 6.8% |
| 278 | Ganglioneuroma | 6.8% |
| 279 | Glioma | 6.8% |
| 280 | Malignant Glioma | 6.8% |
| 281 | Leukemia, Radiation-Induced | 6.7% |
| 282 | Collagen Diseases | 6.7% |
| 283 | Mixed Connective Tissue Disease | 6.7% |
| 284 | Mucinoses | 6.7% |
| 285 | Porphyrias, Hepatic | 6.7% |
| 286 | Mycetoma | 6.5% |
| 287 | Melanoma, Experimental | 6.3% |
| 288 | Lichen Planus, Oral | 6.2% |
| 289 | Peutz-Jeghers Syndrome | 6.2% |
| 290 | Plasmacytoma | 6.2% |
| 291 | Malignant histiocytosis | 6.1% |
| 292 | Histiocytic sarcoma | 6.1% |
| 293 | Cystadenocarcinoma | 6% |
| 294 | Mucoepidermoid Carcinoma | 6% |
| 295 | Larva Migrans | 6% |
| 296 | Leishmaniasis | 6% |
| 297 | Molluscum Contagiosum | 6% |
| 298 | Medulloblastoma | 6% |
| 299 | Angioedema | 5.9% |
| 300 | Onchocerciasis | 5.9% |
| 301 | Thymoma | 5.9% |
| 302 | Neoplasms, Radiation-Induced | 5.9% |
| 303 | Chromoblastomycosis | 5.9% |
| 304 | Dermatophytosis | 5.9% |
| 305 | Sporotrichosis | 5.9% |
| 306 | Tinea | 5.9% |
| 307 | Tinea Versicolor | 5.9% |
| 308 | Trichophytosis | 5.9% |
| 309 | Hyalohyphomycosis | 5.9% |
| 310 | Acute Generalized Exanthematous Pustulosis | 5.8% |
| 311 | Carcinoid Tumor | 5.8% |
| 312 | Neurilemmoma | 5.8% |
| 313 | Hutchinson's Melanotic Freckle | 5.8% |
| 314 | Melanoma, Amelanotic | 5.8% |
| 315 | Leukemia L1210 | 5.7% |
| 316 | Leukemia P388 | 5.7% |
| 317 | Acanthoma | 5.7% |
| 318 | Multiple Endocrine Neoplasia | 5.6% |
| 319 | Choriocarcinoma | 5.4% |
| 320 | Cartilage Diseases | 5.3% |
| 321 | Rheumatism | 5.3% |
| 322 | Chondromalacia | 5.3% |
| 323 | Lupus Erythematosus, Systemic | 5.1% |
| 324 | Overlap syndrome | 5.1% |
| 325 | Warts | 5% |
| 326 | Abdominal Neoplasms | 5% |
| 327 | Erythroplasia | 5% |
| 328 | Follicular cyst | 5% |
| 329 | Head and Neck Neoplasms | 5% |
| 330 | Mucocele | 5% |
| 331 | Pilonidal Cyst | 5% |
| 332 | Soft Tissue Neoplasms | 5% |
| 333 | Thoracic Neoplasms | 5% |
| 334 | Thyroglossal Cyst | 5% |
| 335 | Synovial Cyst | 5% |
| 336 | Aberrant Crypt Foci | 5% |
| 337 | Candidiasis, Chronic Mucocutaneous | 4.9% |
| 338 | Cutaneous Candidiasis | 4.9% |
| 339 | Hodgkin Disease | 4.9% |
| 340 | Lymphoma, Non-Hodgkin | 4.9% |
| 341 | Erysipelas | 4.9% |
| 342 | Serum Sickness | 4.9% |
| 343 | Staphylococcal Skin Infections | 4.9% |
| 344 | Variegate Porphyria | 4.9% |
| 345 | Acute intermittent porphyria | 4.9% |
| 346 | Porphyria Cutanea Tarda | 4.9% |
| 347 | Leishmaniasis, Cutaneous | 4.9% |
| 348 | Eczema Herpeticum | 4.9% |
| 349 | Adenocarcinoma | 4.9% |
| 350 | Carcinoma in Situ | 4.9% |
| 351 | Carcinoma, Transitional Cell | 4.9% |
| 352 | Dysgerminoma | 4.9% |
| 353 | Erythrasma | 4.9% |
| 354 | Hemangioendothelioma | 4.9% |
| 355 | Neuroma | 4.9% |
| 356 | Papilloma | 4.9% |
| 357 | Pseudomyxoma Peritonei | 4.9% |
| 358 | Seminoma | 4.9% |
| 359 | Papillomatosis | 4.9% |
| 360 | Adenomatosis, Pulmonary | 4.9% |
| 361 | Adenomatous Polyps | 4.9% |
| 362 | Carcinoma, Large Cell | 4.9% |
| 363 | Carcinoma, Small Cell | 4.9% |
| 364 | CREST Syndrome | 4.9% |
| 365 | Arthritis, Psoriatic | 4.8% |
| 366 | Fusariosis | 4.8% |
| 367 | Bowen's Disease | 4.8% |
| 368 | Paraganglioma | 4.8% |
| 369 | Astrocytoma | 4.8% |
| 370 | Ependymoma | 4.8% |
| 371 | oligodendroglioma | 4.8% |
| 372 | Ganglioglioma | 4.8% |
| 373 | gliosarcoma | 4.8% |
| 374 | Anaplastic astrocytoma | 4.8% |
| 375 | Anaplastic Oligodendroglioma | 4.8% |
| 376 | Paraneoplastic Encephalomyelitis | 4.7% |
| 377 | Mammary Neoplasms, Experimental | 4.7% |
| 378 | Retinoblastoma | 4.4% |
| 379 | Scleromyxedema | 4.4% |
| 380 | Giant Cell Arteritis | 4.3% |
| 381 | Temporal Arteritis | 4.3% |
| 382 | Hereditary Angioedema Type III | 4.3% |
| 383 | Hereditary Angioedema Types I and II | 4.3% |
| 384 | Malignant Carcinoid Syndrome | 4.3% |
| 385 | Nephroblastoma | 4.2% |
| 386 | Tuberous Sclerosis | 4.1% |
| 387 | Angioedemas, Hereditary | 4.1% |
| 388 | Primary amyloidosis | 4.1% |
| 389 | Epidermodysplasia Verruciformis | 4.1% |
| 390 | Herpes Labialis | 4.1% |
| 391 | Lymphomatoid Granulomatosis | 4.1% |
| 392 | Diabetic Foot | 4.1% |
| 393 | Staphylococcal Scalded Skin Syndrome | 4% |
| 394 | Digestive System Neoplasms | 4% |
| 395 | Endocrine Gland Neoplasms | 4% |
| 396 | Eye Neoplasms | 4% |
| 397 | Nervous System Neoplasms | 4% |
| 398 | Bone neoplasms | 3.8% |
| 399 | Leukoplakia | 3.8% |
| 400 | Lymphocele | 3.8% |
| 401 | Pancreatic Cyst | 3.8% |
| 402 | Hematologic Neoplasms | 3.8% |
| 403 | Glioblastoma | 3.8% |
| 404 | Neuroblastoma | 3.8% |
| 405 | Glioblastoma Multiforme | 3.8% |
| 406 | Barrett Esophagus | 3.8% |
| 407 | Mediastinal Cyst | 3.8% |
| 408 | Neoplasm Invasiveness | 3.8% |
| 409 | Neoplasm Metastasis | 3.8% |
| 410 | Neoplasm Recurrence, Local | 3.8% |
| 411 | Parovarian Cyst | 3.8% |
| 412 | Pericardial Cyst | 3.8% |
| 413 | Splenic Neoplasms | 3.8% |
| 414 | Thymic Cyst | 3.8% |
| 415 | Carcinogenesis | 3.8% |
| 416 | Metastasis | 3.8% |
| 417 | Blastomycosis | 3.7% |
| 418 | Leukemia, Myelomonocytic, Chronic | 3.6% |
| 419 | HIV-Associated Lipodystrophy Syndrome | 3.6% |
| 420 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.6% |
| 421 | Pheochromocytoma | 3.6% |
| 422 | carbuncle | 3.6% |
| 423 | Condylomata Acuminata | 3.5% |
| 424 | Furunculosis | 3.5% |
| 425 | furuncle | 3.5% |
| 426 | Impetigo | 3.4% |
| 427 | Mesoblastic Nephroma | 3.4% |
| 428 | Basal Cell Nevus Syndrome | 3.4% |
| 429 | Mesenteric Panniculitis | 3.3% |
| 430 | Panniculitis, Peritoneal | 3.3% |
| 431 | Tietze's Syndrome | 3.3% |
| 432 | Orbital Cellulitis | 3.3% |
| 433 | Rhinoscleroma | 3.3% |
| 434 | Ganglioneuroblastoma | 3.3% |
| 435 | Cellulitis | 3.3% |
| 436 | Myxedema | 3.3% |
| 437 | Hepatocellular Adenoma | 3.3% |
| 438 | Menkes Kinky Hair Syndrome | 3.2% |
| 439 | Adenoid Cystic Carcinoma | 3.2% |
| 440 | Adenocarcinoma, Clear Cell | 3.2% |
| 441 | Cholangiocarcinoma | 3.2% |
| 442 | Cervical Intraepithelial Neoplasia | 3.2% |
| 443 | Hemangioblastoma | 3.2% |
| 444 | Lymphoma, Extranodal NK-T-Cell | 3.2% |
| 445 | Waldenstrom Macroglobulinemia | 3.1% |
| 446 | Multiple Myeloma | 3.1% |
| 447 | Multiple Endocrine Neoplasia Type 1 | 3% |
| 448 | Carcinoid Heart Disease | 3% |
| 449 | Sturge-Weber Syndrome | 3% |
| 450 | Carcinoma, Pancreatic Ductal | 3% |
| 451 | Corpus Luteum Cyst | 3% |
| 452 | Ovarian Cysts | 3% |
| 453 | Hemangioma, Cavernous | 2.9% |
| 454 | Leukemia, T-Cell | 2.9% |
| 455 | Leukemia, B-Cell | 2.9% |
| 456 | neurofibroma | 2.9% |
| 457 | Hydatidiform Mole | 2.9% |
| 458 | Lymphoma, Follicular | 2.9% |
| 459 | T-Cell Lymphoma | 2.9% |
| 460 | Mantle cell lymphoma | 2.9% |
| 461 | Liver Neoplasms, Experimental | 2.8% |
| 462 | Parathyroid Neoplasms | 2.8% |
| 463 | Peritoneal Neoplasms | 2.8% |
| 464 | Thyroid Neoplasm | 2.8% |
| 465 | Thyroid carcinoma | 2.8% |
| 466 | Prolactinoma | 2.8% |
| 467 | Growth Hormone-Secreting Pituitary Adenoma | 2.8% |
| 468 | Acoustic Neuroma | 2.7% |
| 469 | Retroperitoneal Neoplasms | 2.7% |
| 470 | Osteochondritis | 2.7% |
| 471 | Polymyalgia Rheumatica | 2.7% |
| 472 | Osteogenesis Imperfecta | 2.7% |
| 473 | Keloid | 2.6% |
| 474 | Choledochal Cyst | 2.5% |
| 475 | Noonan Syndrome | 2.5% |
| 476 | Optic Nerve Glioma | 2.5% |
| 477 | Pancreatic Neoplasm | 2.4% |
| 478 | Adenomatous Polyposis Coli | 2.4% |
| 479 | granulosa cell tumor | 2.4% |
| 480 | Carcinoma, Ovarian Epithelial | 2.4% |
| 481 | Klatskin Tumor | 2.4% |
| 482 | Leukemia, Myeloid, Chronic-Phase | 2.4% |
| 483 | Vipoma | 2.3% |
| 484 | Rheumatoid Arthritis | 2.3% |
| 485 | Juvenile arthritis | 2.3% |
| 486 | Tracheal Neoplasms | 2.2% |
| 487 | Marfan Syndrome | 2.2% |
| 488 | Leukoplakia, Oral | 2.2% |
| 489 | Paraneoplastic Cerebellar Degeneration | 2.2% |
| 490 | Homocystinuria | 2.2% |
| 491 | Lupus Nephritis | 2.2% |
| 492 | Mouth Neoplasms | 2.1% |
| 493 | Central Nervous System Neoplasms | 2.1% |
| 494 | Vascular Neoplasms | 2.1% |
| 495 | Thymus Neoplasms | 2.1% |
| 496 | Genital Neoplasms, Female | 2.1% |
| 497 | Pancreatic Pseudocyst | 2.1% |
| 498 | Lymphatic Metastasis | 2% |
| 499 | Neoplasms, Unknown Primary | 2% |
| 500 | Leukemic Infiltration | 2% |
| 501 | Neoplasm Micrometastasis | 2% |
| 502 | insulinoma | 2% |
| 503 | Rheumatoid Nodule | 2% |
| 504 | Laryngomalacia | 1.9% |
| 505 | Pectus carinatum | 1.9% |
| 506 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.9% |
| 507 | Leukemia, Large Granular Lymphocytic | 1.9% |
| 508 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.9% |
| 509 | Lymphoma, T-Cell, Cutaneous | 1.9% |
| 510 | Lymphoma, AIDS-Related | 1.9% |
| 511 | Enteropathy-Associated T-Cell Lymphoma | 1.9% |
| 512 | Primary Effusion Lymphoma | 1.9% |
| 513 | Esophageal Neoplasms | 1.9% |
| 514 | Nasopharyngeal carcinoma | 1.9% |
| 515 | Limbic Encephalitis | 1.9% |
| 516 | Adrenocortical carcinoma | 1.8% |
| 517 | Denys-Drash Syndrome | 1.8% |
| 518 | Gastrinoma | 1.7% |
| 519 | Glucagonoma | 1.7% |
| 520 | Adrenal Gland Neoplasms | 1.7% |
| 521 | Gastrointestinal Neoplasms | 1.7% |
| 522 | Genital Neoplasms, Male | 1.7% |
| 523 | Liver neoplasms | 1.7% |
| 524 | Uveal Neoplasms | 1.7% |
| 525 | Leydig Cell Tumor | 1.7% |
| 526 | Urologic Neoplasms | 1.7% |
| 527 | Lambert-Eaton Myasthenic Syndrome | 1.7% |
| 528 | Testicular Neoplasms | 1.7% |
| 529 | Spinal Neoplasms | 1.7% |
| 530 | Bone Marrow Neoplasms | 1.7% |
| 531 | Felty Syndrome | 1.6% |
| 532 | Thyroid Nodule | 1.6% |
| 533 | Bronchomalacia | 1.6% |
| 534 | Tracheomalacia | 1.6% |
| 535 | Polycystic Ovary Syndrome | 1.6% |
| 536 | Renal Cell Carcinoma | 1.6% |
| 537 | Papillary Renal Cell Carcinoma | 1.6% |
| 538 | Carcinoma, Endometrioid | 1.5% |
| 539 | Opsoclonus-Myoclonus Syndrome | 1.5% |
| 540 | Mycosis Fungoides | 1.4% |
| 541 | Lymphomatoid Papulosis | 1.4% |
| 542 | Plasmablastic lymphoma | 1.4% |
| 543 | Rheumatoid Vasculitis | 1.4% |
| 544 | Burkitt Lymphoma | 1.4% |
| 545 | Mucopolysaccharidosis III | 1.4% |
| 546 | Myelitis, Transverse | 1.3% |
| 547 | Sicca Syndrome | 1.2% |
| 548 | Sjogren's Syndrome | 1.2% |
| 549 | Meningeal Neoplasms | 1.2% |
| 550 | ovarian neoplasm | 1.2% |
| 551 | Nose Neoplasms | 1.1% |
| 552 | Sezary Syndrome | 1% |
| 553 | Pituitary Adenoma | 1% |
| 554 | Pituitary Neoplasms | 1% |
| 555 | Palatal Neoplasms | 1% |
| 556 | Ear Neoplasms | 1% |
| 557 | Eyelid Neoplasms | 1% |
| 558 | Lung Neoplasms | 1% |
| 559 | Pleural Neoplasms | 1% |
| 560 | Lupus Vasculitis, Central Nervous System | 1% |
| 561 | Cell Transformation, Viral | 1% |
| 562 | Brain Neoplasms | 1% |
| 563 | Salivary Gland Neoplasms | 1% |
| 564 | Spinal Cord Neoplasms | 1% |
| 565 | Tongue Neoplasms | 1% |
| 566 | Uterine Neoplasms | 1% |
| 567 | Vaginal Neoplasms | 1% |
| 568 | Vulvar Neoplasms | 1% |
| 569 | Uterine Cancer | 1% |
| 570 | Fallopian Tube Neoplasms | 1% |
| 571 | Mucopolysaccharidosis II | 1% |
| 572 | Zollinger-Ellison syndrome | 0.9% |
| 573 | Pharyngeal Neoplasms | 0.8% |
| 574 | Central Nervous System Cysts | 0.8% |
| 575 | Bile Duct Neoplasms | 0.8% |
| 576 | gallbladder neoplasm | 0.8% |
| 577 | Intestinal Neoplasms | 0.8% |
| 578 | Penile Neoplasms | 0.8% |
| 579 | Prostatic Neoplasms | 0.8% |
| 580 | Stomach Neoplasms | 0.8% |
| 581 | Polycythemia Vera | 0.8% |
| 582 | Meningeal Carcinomatosis | 0.8% |
| 583 | Laryngeal neoplasm | 0.7% |
| 584 | Bladder Neoplasm | 0.7% |
| 585 | Kidney Neoplasm | 0.7% |
| 586 | Ureteral Neoplasms | 0.7% |
| 587 | Urethral Neoplasms | 0.7% |
| 588 | Bronchial Neoplasms | 0.7% |
| 589 | Multiple Pulmonary Nodules | 0.7% |
| 590 | Supratentorial Neoplasms | 0.6% |
| 591 | Endometrial Neoplasms | 0.6% |
| 592 | Hypopharyngeal Neoplasms | 0.5% |
| 593 | Pleural Effusion, Malignant | 0.5% |
| 594 | Hypopharyngeal Cancer | 0.5% |
| 595 | Parotid Neoplasms | 0.5% |
| 596 | Prostatic Neoplasms, Castration-Resistant | 0.5% |
| 597 | Nelson Syndrome | 0.5% |
| 598 | Brain Stem Neoplasms | 0.5% |
| 599 | Cecal Neoplasms | 0.5% |
| 600 | Duodenal Neoplasms | 0.5% |
| 601 | Nasopharyngeal Neoplasms | 0.4% |
| 602 | Colorectal Neoplasms | 0.4% |
| 603 | Tonsillar Neoplasms | 0.4% |
| 604 | Cerebellar Neoplasms | 0.4% |
| 605 | Choroid Plexus Papilloma | 0.4% |
| 606 | Paranasal Sinus Neoplasms | 0.4% |
| 607 | Radicular Cyst | 0.3% |
| 608 | Appendiceal Neoplasms | 0.3% |
| 609 | Colonic Neoplasms | 0.3% |
| 610 | Rectal Neoplasms | 0.3% |
| 611 | Maxillary Sinus Neoplasms | 0.3% |
| 612 | Anus Neoplasms | 0.2% |
| 613 | Sigmoid Neoplasms | 0.2% |